Ultrasound performance using the EU-TIRADS score in the diagnosis of thyroid cancer in Congolese hospitals
Open Access
- 2 November 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-7
Abstract
The thyroid imaging reporting and data systems by the European Thyroid Association (EU-TIRADS) has been widely used in malignancy risk stratification of thyroid nodules. However, there is a paucity of data in developing countries, especially in Africa, to validate the use of this scoring system. The aim of the study was to assess the diagnostic value of the EU-TIRADS score in Congolese hospitals, using pathological examination after surgery as the gold standard in Congolese hospitals. This retrospective and analytical study examined clinical, ultrasound and pathological data of 549 patients aged 45 ± 14 years, including 468 females (85.2%), operated for thyroid nodule between January 2005 and January 2019. In the present study, only the highest graded nodule according to the EU-TIRADS score in each patient was taken into account for the statistical analyses. So 549 nodules were considered. Nodules classified EU-TIRADS 2 and 3 on the one hand, and, on the other hand, 4 and 5, were considered respectively at low and high risk of malignancy. The sensitivity and specificity of the EU-TIRADS score were calculated. The significance level was set at 5%. Of all patients, 21.7% had malignant nodules. They made 48.4% of the nodules in patients younger than and at 20 years old, and 31.1% in those aged 60 or over. Malignant nodules were more frequent in men than in women (30.9% vs. 20.1%; p = 0.024). Papillary carcinoma (67.2%) and follicular carcinoma (21.8%) were the main types. The malignancy rate was 39.7% and 1.5% among nodules rated EU-TIRADS 4 and 5, and those with EU-TIRADS score 2 and 3, respectively (p < 0.001). The EU-TIRADS score had a sensitivity of 96.6% and a specificity of 59.3%. The ROC curve indicated an area under the curve of 0.862. In a low-income country, a well performed thyroid ultrasound, using the EU-TIRADS score, could be an important tool in the selection of thyroid nodules suspected of malignancy and requiring histopathological examination in the Congolese hospital setting.Trial registration: The research protocol had obtained the favorable opinion of the DRC national health ethics committee no. 197/CNES/BN/PMMF/2020. The data was collected and analyzed anonymously.Keywords
This publication has 35 references indexed in Scilit:
- Thyroid Cancer Gender DisparityFuture Oncology, 2010
- Real-Time Elastography for the Differentiation of Benign and Malignant Thyroid Nodules: A Meta-AnalysisThyroid®, 2010
- The Bethesda Thyroid Fine-Needle Aspiration Classification System: Year 1 at an Academic InstitutionThyroid®, 2009
- International patterns and trends in thyroid cancer incidence, 1973–2002Cancer Causes & Control, 2008
- The National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference: a SummationCytojournal, 2008
- Ultrasonographic Evaluation of Thyroid Nodules in 900 Patients: Comparison Among Ultrasonographic, Cytological, and Histological FindingsThyroid®, 2007
- Diagnostic Value of Ultrasonography to Distinguish Between Benign and Malignant Lesions in the Management of Thyroid NodulesThyroid®, 2007
- Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985–1999)European Journal Of Cancer Prevention, 2007
- Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines TaskforceThyroid®, 2006
- Thyroid Cancer in the Thyroid Nodules Evaluated by Ultrasonography and Fine-Needle Aspiration CytologyThyroid®, 2005